Stephen V Liu, MD (@stephenvliu) 's Twitter Profile
Stephen V Liu, MD

@stephenvliu

Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Co-Host @IASLC Podcast; Chair #TexasLung25 #DCLung25; #HereWeGo

ID: 377425889

linkhttps://www.medstarhealth.org/doctors/stephen-liu-md calendar_today21-09-2011 15:17:53

19,19K Tweet

26,26K Followers

3,3K Following

Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo
Stephen V Liu, MD
@stephenvliu

3 months ago

Dr. Jamie Chaft with NEOADAURA at #ASCO25. Neoadjuvant osimertinib alone or with chemo vs neoadjuvant chemo in NSCLC. MPR only 2% with chemo, vs 25% with osi, 26% with osi/chemo. pCR 9% osi, 4% osi/chemo. EFS better for pts who MPR - curious how adjuvant osi contributed to EFS.

Dr. <a href="/ChaftJamie/">Jamie Chaft</a> with NEOADAURA at #ASCO25. Neoadjuvant osimertinib alone or with chemo vs neoadjuvant chemo in NSCLC. MPR only 2% with chemo, vs 25% with osi, 26% with osi/chemo. pCR 9% osi, 4% osi/chemo. EFS better for pts who MPR - curious how adjuvant osi contributed to EFS.